ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.

Department of Transplantology, General, Vascular and Plastic Surgery, Clinical Hospital of Poznan University of Medical Sciences, Poznan, Poland.

Meeting: 2015 American Transplant Congress

Abstract number: D146

Keywords: Calcineurin, Immunosuppression, Kidney transplantation, Rapamycin

Session Information

Session Name: Poster Session D: Kidney Immunosuppression: Drug Minimization

Session Type: Poster Session

Date: Tuesday, May 5, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

The aim of the study was to analyse the clinical outcome in kidney transplant recipients treated with CNI (calcineurin inhibitors)-free protocol versus kidney transplant recipients treated with CNI in our hospital.

Recipients of renal transplant from deceased donors in whom transplantation was performed from June 2013 to November 2014 were included in the study. At baseline, 100 patients were treated with CNI (tacrolimus or cyclosporine A), steroids, and MMF/MPA (CNI group), and 20 patients (9 women, 11 men) received CNI-free protocol, based on everolimus, steroids, MMF/MPA, and basiliximab induction (CNIF group).

Inclusion criteria for CNI-free protocol using de novo mTOR inhibitors were: precancerous conditions or cancers in the medical history of recipients such as colon, laryngeal and gastric polyps (5), breast, testicular, renal cancer (4), benign tumors of the ovary, uterus, thyroid gland, meningioma (6); micropathy in recipients (2), tuberous sclerosis in recipient (1) and fibro-muscular dysplasia in donors (2).

Mean follow-up of the CNIF group was 6 months. Delayed graft function (DGF), occured in 2 patients, lymphocele- in 3 patients, leukopenia- in 1, diarrhea and other gastro-intestinal disorders- in 4. Acute graft rejection, acute tubular necrosis, diabetes de novo, viral infections, dyslipidemia, liver failure have not been observed in any of the CNIF patients. Mean systolic blood pressure was 128.9 +/- 14.5 and diastolic- 80 +/- 11.1 mmHg.

Wound infections, poor wound healing and bacterial infections occurred with comparable frequency in both groups but results lacked sufficient statistical power. The primary end point was estimated GFR, as calculated by the Cockcroft Gault formula 6 month after kidney transplantation and in the CNIF group was 52.2 +/- 29.3 ml per minute vs 65.36 +/- 21 ml/min in CNI group Tacrolimus/Cyclosporine (p = 0,01).

The short-term result assessing the efficacy of everolimus/MMF(MPA)/steroids regimen are promising and comparable with using CNI protocol but require further observation and research.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Stronka M, Adamska Z, Cichanska L, Kubiak J, Gamrat M, Karczewski M. Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/calcineurin-inhibitor-free-immunossupresion-after-kidney-transplantation-using-everolimus-de-novo-single-center-experience/. Accessed June 7, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences